ROMANO, Claudio
 Distribuzione geografica
Continente #
EU - Europa 8.883
NA - Nord America 6.785
AS - Asia 4.952
SA - Sud America 1.791
AF - Africa 154
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 6
Totale 22.583
Nazione #
US - Stati Uniti d'America 6.578
RU - Federazione Russa 4.672
SG - Singapore 2.032
BR - Brasile 1.507
CN - Cina 1.316
IE - Irlanda 1.158
SE - Svezia 985
IT - Italia 662
HK - Hong Kong 537
VN - Vietnam 347
DE - Germania 273
FR - Francia 268
PL - Polonia 199
GB - Regno Unito 176
IN - India 170
UA - Ucraina 129
FI - Finlandia 122
AR - Argentina 98
BD - Bangladesh 86
MX - Messico 85
ID - Indonesia 67
TR - Turchia 65
CA - Canada 61
AT - Austria 52
IQ - Iraq 48
ZA - Sudafrica 48
CO - Colombia 46
EC - Ecuador 45
UZ - Uzbekistan 42
NL - Olanda 41
JP - Giappone 31
VE - Venezuela 30
MA - Marocco 29
ES - Italia 27
BE - Belgio 23
PK - Pakistan 23
AZ - Azerbaigian 19
CL - Cile 19
SA - Arabia Saudita 18
PY - Paraguay 17
TN - Tunisia 16
LT - Lituania 15
PH - Filippine 15
AE - Emirati Arabi Uniti 14
KE - Kenya 14
NP - Nepal 13
CR - Costa Rica 12
KR - Corea 12
BO - Bolivia 11
EG - Egitto 11
JM - Giamaica 11
JO - Giordania 11
MY - Malesia 11
AL - Albania 10
PE - Perù 9
UY - Uruguay 9
DZ - Algeria 8
EU - Europa 8
KZ - Kazakistan 8
BY - Bielorussia 7
IL - Israele 7
LV - Lettonia 7
OM - Oman 7
TH - Thailandia 7
AM - Armenia 6
BG - Bulgaria 6
DO - Repubblica Dominicana 6
HN - Honduras 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
GR - Grecia 5
HU - Ungheria 5
IR - Iran 5
RO - Romania 5
AU - Australia 4
BH - Bahrain 4
CH - Svizzera 4
CI - Costa d'Avorio 4
EE - Estonia 4
GT - Guatemala 4
MK - Macedonia 4
PA - Panama 4
PS - Palestinian Territory 4
RS - Serbia 4
SN - Senegal 4
TW - Taiwan 4
DK - Danimarca 3
GA - Gabon 3
GE - Georgia 3
NI - Nicaragua 3
PT - Portogallo 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
CZ - Repubblica Ceca 2
GD - Grenada 2
LB - Libano 2
Totale 22.546
Città #
Moscow 1.401
Ashburn 1.312
Dublin 1.118
Singapore 1.047
Chandler 745
Dallas 710
Hong Kong 534
Beijing 495
Nyköping 447
Messina 311
San Jose 281
Jacksonville 273
Princeton 202
Warsaw 192
Lauterbourg 166
The Dalles 161
Los Angeles 147
Dearborn 141
Medford 135
Ho Chi Minh City 124
Des Moines 121
São Paulo 110
Munich 92
Council Bluffs 87
New York 87
Ann Arbor 78
Buffalo 76
Redondo Beach 70
Hanoi 65
Guangzhou 60
Boardman 57
Tianjin 55
Orem 53
Wilmington 51
Cambridge 48
Santa Clara 46
Menlo Park 43
Rio de Janeiro 37
Frankfurt am Main 35
Jakarta 35
Tashkent 35
Turku 35
Vienna 34
Jinan 33
Nanjing 33
Chennai 32
Seattle 32
London 31
Belo Horizonte 30
Brooklyn 30
Rome 30
Brasília 27
Istanbul 26
Woodbridge 26
Hyderabad 25
Milan 25
Tokyo 25
Curitiba 24
Johannesburg 24
Lappeenranta 24
Mexico City 24
Brussels 23
Amsterdam 22
Chicago 22
Hangzhou 22
Baghdad 20
Dhaka 20
Nuremberg 20
Dong Ket 19
Manchester 19
Palermo 19
Shenyang 19
Recife 18
San Francisco 18
San Mateo 18
Stockholm 18
Baku 17
Bogotá 17
Da Nang 17
Naples 17
Campinas 16
Düsseldorf 16
Helsinki 16
Houston 16
Montreal 16
Phoenix 16
Shenzhen 16
Atlanta 15
Denver 15
Mumbai 15
Porto Alegre 15
Pune 15
Quito 15
Guayaquil 14
Hebei 14
Boston 13
Osasco 13
Zhengzhou 13
Ankara 12
Catania 12
Totale 12.511
Nome #
Acute pulmonary exacerbation and lung function decline in patients with cystic fibrosis: high-mobility group box 1 (HMGB1) between inflammation and infection. 263
Autoimmune liver disease in Noonan Syndrome. 230
Acute Malnutrition in Children: Pathophysiology, Clinical Effects and Treatment 206
A Narrative Review on Efficacy and Safety of Proton Pump Inhibitors in Children 194
Lactobacillus reuteri in children with functional abdominal pain 193
Gastric volvulus in children - A diagnostic problem: Two case reports 191
Adverse reactions related to proton pump inhibitors in pediatric population: an analysis of spontaneous reporting data 190
A propensity score-matched comparison of infliximab and adalimumab in TNF-α inhibitors naïve and non-naïve patients with Crohn's disease: real-life data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 183
Clinical significance of NOD2/CARD15 and Toll-like receptor 4 gene single nucleotide polymorphisms in inflammatory bowel disease. 176
Biological therapy in pediatric inflammatory bowel disease a systematic review 176
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience. 172
Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children 171
Standard polymeric formula tube feeding in neurologically impaired children: A five-year retrospective study 171
Intestinal and neurological involvement in Behcet disease: A clinical case 170
Appropriate age at solid introduction: is EFSA extending the individualised window on a sounding scientific evidence? 170
Managing Pediatric Foreign Body Ingestions: A 10-Year Experience 170
Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. 167
Pediatric gastrointestinal bleeding: Perspectives from the Italian Society of Pediatric Gastroenterology 164
Misdiagnosis of celiac disease (CD) and Systemic nickel allergy syndrome (SNAS): which overlaps? 163
Oral beclomethasone diproprionate in pediatric active ulcerative colitis: a comparison trial with mesalazine. 158
Caregiver Social Status and Health-Related Quality of Life in Neurologically Impaired Children on Home Enteral Nutrition 158
Fibers in pediatric functional gastrointestinal disorders. Practical considerations from clinical cases 157
Azathioprine/6-Mercaptopurine in the treatment of inflammatory bowel disease (IBD)- A single centre experience 155
Systemic lupus erithematosus and celiac disease 153
Pericarditis during infliximab therapy in paediatric ulcerative colitis 153
Paediatric ulcerative colitis surgery: Italian Survey 150
Antiemetic Drug Use in Children: What the Clinician Needs to Know 150
An overview of the clinical management of cyclic vomiting syndrome in childhood 150
Biosimilar infliximab in paediatric inflammatory bowel disease: Efficacy, immunogenicity and safety 149
Antibiotic Prophylaxis for Percutaneous Endoscopic Gastrostomy in Children: A Randomised Controlled Trial 149
Laparoscopic robotic-assisted restorative proctocolectomy and ileal J-pouch-anorectal anastomosis in children 149
Polymorphisms of IRGM gene predispose to fistulizing behaviour in adult and pediatric Crohn's disease 148
Functional Dyspepsia: An Enigma in a Conundrum 148
Probiotics' efficacy in paediatric diseases: which is the evidence? A critical review on behalf of the Italian Society of Pediatrics 147
Raman spectroscopy technique: A non-invasive tool in celiac disease diagnosis 145
Effectiveness and safety of biologics in pediatric inflammatory boweldisease: Real-life data from the Sicilian Network 144
Biosimilars in Pediatric Inflammatory Bowel Diseases: A Systematic Review and Real Life-Based Evidence 144
Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD) 143
Cutaneous small-vessel vasculitis associated with paediatric ulcerative colitis: A case study and literature review 143
Complementary feeding: new styles versus old myths 143
VSL#3 Improves Symptoms in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Placebo-Controlled, Double-Blind, Crossover Study 141
A Rare Case of Esophageal Dysphagia in Children: Aberrant Right Subclavian Artery 141
Pancreatic involvement in pediatric inflammatory bowel diseases 141
Vaccination strategies in pediatric inflammatory bowel disease 141
Colectomy and health-related quality of life in children with ulcerative colitis 141
Clinical significante of NOD2/CARD15 and TLR4 gene SNPs in inflammatory bowel disease 140
Recognizing the Emergent and Submerged Iceberg of the Celiac Disease: ITAMA Project—Global Strategy Protocol 139
Intestinal Behcet and Crohn's disease: Two sides of the same coin 139
SU UN CASO DI SINDROME DI SHWACHMAN-DIAMOND 138
Management of acute severe colitis in children with ulcerative colitis in the biologics Era 137
Factors that influence infliximab biosimilar trough levels in the pediatric inflammatory bowel disease population 136
Inflammatory bowel disease: genetics, epigenetics, and pathogenesis 136
Current topics in the diagnosis and management of the pediatric non organic feeding disorders (NOFEDs) 136
Phenotype and disease course of early-onset pediatric inflammatory bowel disease 135
Thalidomide for de novo Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis 135
The management of colonic polyps in children: a 13-year retrospective study 134
Clinical features and long-term outcomes in pediatric cyclic vomiting syndrome: A 9-year experience at three tertiary academic centers 134
Gastrointestinal symptoms in children: Primary care and specialist interface 133
Is there a risk of pubertal worsening in primary intestinal lymphangiectasia? 133
Efficacy of adalimumab as second-line therapy in a pediatric cohort of crohn’s disease patients who failed infliximab therapy: The Italian society of pediatric gastroenterology, hepatology, and nutrition experience 133
Health-Related Quality of Life and Home Enteral Nutrition in Children with Neurological Impairment: Report from a Multicenter Survey 133
Pancreatic associated manifestations in pediatric inflammatory bowel diseases 133
Challenges in paediatric inflammatory bowel diseases in the COVID-19 time 132
Vaccinations and Immune Response in Celiac Disease 131
Diet and nutrition in pediatric inflammatory bowel diseases 131
Prevalence and Risk Factors of Functional Gastrointestinal Disorders: A Cross-Sectional Study in Italian Infants and Young Children 130
Nonalcoholic Fatty Liver Disease/non-alcoholic steatohepatitis in childhood: Endocrine-metabolic "mal-programming" 130
Twelve Novel Mutations in the SLC26A3 Gene in 17 Sporadic Cases of Congenital Chloride Diarrhea 130
Probiotic supplementation in systemic nickel allergy syndrome patients: study of its effects on lactic acid bacteria population and on clinical symptoms 130
Surgery-related quality of life of pediatric patients with Crohn's disease 130
Partially hydrolyzed guar gum in pediatric functional abdominal pain 129
Gluten-related disorders: certainties, questions and doubts 129
Cyclic vomiting syndrome in children: a nationwide survey of current practice on behalf of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP) and Italian Society of Pediatric Neurology (SINP) 128
Spontaneous reporting of adverse reactions related to proton pump inhibitors 127
Polymorphisms of IRGM gene predispose to fistulizing behaviour in adult and pediatric Crohn's disease 126
Clinical features and risk factors of autoimmune liver involvement in pediatric inflammatory bowel disease 126
Systemic steroids have a role in treating esophageal strictures in pediatric eosinophilic esophagitis 126
Genotype/phenotype analysis of a panel of genes in paediatric patients with IBD: A multicentre study of SIGENP 125
Resezione endoscopica di membrana duodenale tipo "manica a vento" 124
Vedolizumab-associated pulmonary manifestations in children with ulcerative colitis 123
Vaccinations and immunization status in Paediatric inflammatory bowel disease: data from the VIP IBD study 122
Italian survey on non-steroidal anti-inflammatory drugs and gastrointestinal bleeding in children 121
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study 121
Pediatric gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) and European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Guideline Executive summary 119
Polymorphisms of IRGM gene predispose to fistulizing behaviour in adult and pediatric Crohn's disease 117
Vulvar involvement in pediatric Crohn’s disease: a systematic review 117
Genotype/Phenotype Analysis of a Panel of Genes in Pediatric Patients With IBD 117
Pulmonary implications in inflammatory bowel disease: not a rare event 117
Pharmacological treatments and infectious diseases in pediatric inflammatory bowel disease 117
Peculiarità genetiche delle MICI 116
Impact of COVID-19 pandemic on the management of paediatric inflammatory bowel disease: An Italian multicentre study on behalf of the SIGENP IBD Group: Impact of the lockdown on IBD management in children 116
Nutrition in pediatric gastroenterology 115
Disease activity patterns in the first 5 years after diagnosis in children with ulcerative colitis: a population-based study 115
Occurrence and Clinical Impact of Eosinophilic Esophagitis in a Large Cohort of Children With Inflammatory Bowel Disease 114
Functional aerophagia in children: A frequent, atypical disorder 114
Duodenal Duplication Cysts in Children: Clinical Features and Current Treatment Choices 114
Minimal invasive approach to paediatric colorectal surgery 114
Current issues in pediatric inflammatory bowel diseaseassociated arthropathies 113
Real-Life Use of Biosimilars in Pediatric Inflammatory Bowel Disease: A Nation-Wide Web Survey on Behalf of the SIGENP IBD Working Group 113
A Systematic Review to Manage Avoidant/Restrictive Food Intake Disorders in Pediatric Gastroenterological Practice 111
Totale 14.295
Categoria #
all - tutte 83.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 0 0 46
2021/20221.506 12 66 13 310 103 12 61 68 50 251 154 406
2022/20232.886 224 258 130 222 169 276 36 144 1.328 12 67 20
2023/2024731 60 121 67 83 62 92 13 61 17 40 13 102
2024/20254.042 52 64 66 289 245 111 99 742 978 305 356 735
2025/202611.896 621 781 860 805 1.019 2.360 1.363 1.488 1.449 565 305 280
Totale 23.102